Reactivation and role of HHV-8 in Kaposi's sarcoma initiation.
about
Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANAMolecular biology of KSHV in relation to AIDS-associated oncogenesis.Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma.Induction of angiogenic chemokine CCL2 by human herpesvirus 8 chemokine receptor.Insights into pathogenic events of HIV-associated Kaposi sarcoma and immune reconstitution syndrome related Kaposi sarcoma.Interplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.Kaposi's sarcoma and human chorionic gonadotropin: mechanisms, moieties and mysteries.A novel role of hydrogen peroxide in Kaposi sarcoma-associated herpesvirus reactivation.Development of new antivirals for herpesviruses.Distinct domains in ORF52 tegument protein mediate essential functions in murine gammaherpesvirus 68 virion tegumentation and secondary envelopmentUse of boosted protease inhibitors reduces Kaposi sarcoma incidence among male veterans with HIV infection.Antitumour effects of antiretroviral therapy.Murine gammaherpesvirus 68 ORF52 encodes a tegument protein required for virion morphogenesis in the cytoplasm.Immune disorders and susceptibility to neoplasmsReactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathwaysIntracellular localization map of human herpesvirus 8 proteins.Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death.High Glucose Induces Reactivation of Latent Kaposi's Sarcoma-Associated HerpesvirusPharmacological management of Kaposi's sarcoma.Changing Incidence and Risk Factors for Kaposi Sarcoma by Time Since Starting Antiretroviral Therapy: Collaborative Analysis of 21 European Cohort Studies.Diagnosis and Treatment of Kaposi Sarcoma.Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequenceModulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus.Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.Promotion of Endoplasmic Reticulum-Associated Degradation of Procathepsin D by Human Herpesvirus 8-Encoded Viral Interleukin-6.Human herpesvirus 8 interleukin-6 contributes to primary effusion lymphoma cell viability via suppression of proapoptotic cathepsin D, a cointeraction partner of vitamin K epoxide reductase complex subunit 1 variant 2.Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability.Human Herpesvirus 8 and Lymphoproliferative Disorders
P2860
Q28388436-BB5B132B-1FEF-4F40-94B2-B22943C37C37Q28474913-0131DFAC-D06F-446A-8039-6EC17E0223FFQ33560572-80280FF6-D34F-43C6-9AEC-2B8670C9617FQ33844645-4AACDF2A-FC53-4C94-B3E0-1048A54FABF0Q34508261-F623DD84-7092-4EF8-A96F-1018B20668E6Q34587349-719041C0-E763-477E-BBE7-34A871383E44Q34615002-FEF4F0FD-9D7C-4FCE-855A-B9264F97906BQ35000748-C87CC820-B1CF-4DE6-9FA4-2783385EB79CQ35600718-15B50B92-F6C0-453C-A2AF-72ECF55DA36AQ35669533-C48919C4-3317-4FA2-8A1A-618800E47E92Q35689584-B5B33805-7E8F-4CDD-ADE6-467938CCE6BCQ35715660-24C9BD14-984E-4736-859B-DEA6277DB877Q35934144-50F59D26-2836-4605-8FD8-FA63ACEDCB56Q36098926-01ADB3C4-DBEF-49FE-AD5B-B4E9430D7A8DQ36101742-85CF27D1-F1DC-4A05-9861-9802D10E67D8Q36454456-D60C4CD2-C771-411D-B67B-B61C3CAC73EBQ36483264-C3F60DA4-4991-41C1-A368-B629D5F2DC5AQ37033342-68172DAE-BFC1-462A-969D-EF8DA943AF33Q37347292-B97E6E62-2C6C-4830-AE8E-C68F84B005D4Q37868566-269FDECD-AB47-44D7-8409-6C7EDBE82E25Q38404819-3825ED6A-FC84-4260-AE52-6C6A25DDFC09Q39190555-6DBCEAC1-5057-4C93-A978-15C8810331C4Q39733480-0496A640-5473-408B-93E8-91B1E191C77CQ40218296-38EE5936-301A-466B-B1AD-CF7ACD039748Q40287215-A9608969-8615-410D-9AEB-125A3E7D1FDBQ40896288-06AAE7B7-CF8B-4DF3-AB1A-D9F1B9110346Q41909015-C6ACC290-5EC0-4207-8DB1-AB6ED5A8B71AQ42052945-9C69F69A-2B2D-425E-89FF-C175EFD6C8DFQ58701113-EA7188BE-82AD-4F8F-AE7E-FEBF347AD5B6
P2860
Reactivation and role of HHV-8 in Kaposi's sarcoma initiation.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Reactivation and role of HHV-8 in Kaposi's sarcoma initiation.
@ast
Reactivation and role of HHV-8 in Kaposi's sarcoma initiation.
@en
Reactivation and role of HHV-8 in Kaposi's sarcoma initiation.
@nl
type
label
Reactivation and role of HHV-8 in Kaposi's sarcoma initiation.
@ast
Reactivation and role of HHV-8 in Kaposi's sarcoma initiation.
@en
Reactivation and role of HHV-8 in Kaposi's sarcoma initiation.
@nl
prefLabel
Reactivation and role of HHV-8 in Kaposi's sarcoma initiation.
@ast
Reactivation and role of HHV-8 in Kaposi's sarcoma initiation.
@en
Reactivation and role of HHV-8 in Kaposi's sarcoma initiation.
@nl
P2093
P1476
Reactivation and role of HHV-8 in Kaposi's sarcoma initiation.
@en
P2093
P304
P356
10.1016/S0065-230X(01)81005-8
P577
2001-01-01T00:00:00Z